药学学报, 2017, 52(7): 1091-1101
引用本文:
李芳芳, 陆盛胜, 吉腾飞, 何坚. 动物来源放线菌的次级代谢产物及其生物活性研究进展[J]. 药学学报, 2017, 52(7): 1091-1101.
LI Fang-fang, LU Sheng-sheng, JI Teng-fei, HE Jian. Advances in secondary metabolites produced by actinobacteria derived from animal-microbe mutualism and their biological activities[J]. Acta Pharmaceutica Sinica, 2017, 52(7): 1091-1101.

动物来源放线菌的次级代谢产物及其生物活性研究进展
李芳芳1, 陆盛胜1, 吉腾飞2, 何坚1
1. 南方医科大学药学院, 广东 广州 510515;
2. 中国医学科学院、北京协和医学院药物研究所, 北京 100050
摘要:
放线菌是抗生素的主要来源之一,在人类对抗由致病菌产生的感染性疾病的过程中发挥了不可替代的防治作用。近年来,由于耐药菌株的不断涌现,促使人们加快寻找新的抗生素的步伐。寄生于动物体内的共生放线菌,是目前药用微生物资源的一个重要来源,也是当前微生物药物研究领域的一个热点。这些微生物在与动物互生共存的演化过程中,组成了一个动物-细菌共同体,进而构建成为一个协调而相对独立的微生态环境。在这一特殊环境中,放线菌所产生的次级代谢产物,既可被动物机体所耐受,又具有抑制特定病原微生物的活性。这类次级代谢产物种类繁多、结构特异,具有抗细菌、真菌、病毒、肿瘤及免疫调节等多种生物活性,具备开发成为新型药物的巨大潜力。本文旨在总结近十年来关于动物来源放线菌的次级代谢产物及其生物学活性的研究进展,为进一步开发新型药物提供参考和研究策略。
关键词:    放线菌      次级代谢产物      生物活性      动物-细菌共同体     
Advances in secondary metabolites produced by actinobacteria derived from animal-microbe mutualism and their biological activities
LI Fang-fang1, LU Sheng-sheng1, JI Teng-fei2, HE Jian1
1. School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China;
2. Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Abstract:
Actinobacteria remain to be one of the major sources for new antibiotics, which historically play an essential role in human's fight against infectious diseases. Due to the emergence of resistant pathogenic microorganisms such as bacteria, fungi and viruses, it is imperative to develop new and effective drugs against these pathogens. The symbiotic actinobacteria residing inside the animals are becoming more and more important as a new source for drug discovery, as well as a "hotspot" in the field of microbial medicine. During the long period of evolution, a specific host-microbe mutualism is formed between the symbiotic bacteria and their hosts of animals. In this unique ecosystem, the secondary metabolites produced by bacteria are well tolerated by the hosts, meanwhile, are able to selectively suppress pathogenic microorganisms, thus providing a specific protection to their hosts. These secondary metabolites encompass a large variety of structural diversities of natural products, and so far, the reported biological activities are including antibacterial, antifungal, antiviral, antitumor, and immunomodulatory effects, which give them a great potential in the field of drug discovery. Herein, we review the secondary metabolites of animal symbiotic actinobacteria and their biological activities within the recent decade, by which to provide a viewpoint for future research of drug discovery from actinobacteria.
Key words:    actinobacteria    secondary metabolites    biological activities    host-microbial mutualism   
收稿日期: 2016-12-26
DOI: 10.16438/j.0513-4870.2016-1220
基金项目: 广东省科技厅资助项目(2014A020210014,2015A020211010)
通讯作者: 何坚,Tel/Fax:86-20-61648717,E-mail:jianhe@smu.edu.cn
Email: jianhe@smu.edu.cn
相关功能
PDF(714KB) Free
打印本文
0
作者相关文章
李芳芳  在本刊中的所有文章
陆盛胜  在本刊中的所有文章
吉腾飞  在本刊中的所有文章
何坚  在本刊中的所有文章

参考文献:
[1] Yin J, Straight PD, Hrvatin S, et al. Genome-wide high-throughput mining of natural-product biosynthetic gene clus­ters by phage display [J]. Chem Biol, 2007, 14: 303-312.
[2] Subramani R, Aalbersberg W. Marine actinomycetes: an ongoing source of novel bioactive metabolites [J]. Microbiol Res, 2012, 167: 571-580.
[3] Ikeda H. Natural products discovery from micro-organisms in the post-genome era [J]. Biosci Biotechnol Biochem, 2017, 81: 13-22.
[4] Costello EK, Lauber CL, Hamady M, et al. Bacterial community variation in human body habitats across space and time [J]. Science, 2009, 326: 1694-1697.
[5] Kitahara M, Tsuchida S, Kawasumi K, et al. Bacteroides chinchillae sp. nov. and Bacteroides rodentium sp. nov., isolated from chinchilla(Chinchilla lanigera)faeces. [J]. Int J Syst Evol Micr I, 2011, 61: 877-881.
[6] Morotomi M, Nagai F, Watanabe Y. Description of Chris­tensenella minuta gen. nov., sp. nov., isolated from human faeces, which forms a distinct branch in the order Clostridiales, and proposal of Christensenella ceae fam. nov. [J]. Int J Syst Evol Micr, 2012, 62: 144-149.
[7] Liu KL, Wang JQ, Bu DP, et al. Advances in diversity and functionality of human gut microflora [J]. Acta Ecol Sin(生态学报), 2009, 29: 2589-2594.
[8] Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine [J]. Cell, 2006, 124: 837-848.
[9] Sun YY, Jia XH. Prospect of research on animal intestinal actinomycetes [J]. Tianjin Agric Sci(天津农业科学), 2014,(07): 25-28.
[10] Jiang Y, Cao YR, Han L, et al. Diversity and bioactivity of culturable actinobacteria from animal feces [J]. Acta Microbiol Sin(微生物学报), 2012, 52: 1282-1289.
[11] Zhang M, Fan XB, Hang XM, et al. Distribution of youth intestinal flora and analysis of key probiotics community [J]. Acta Microbiol Sin(微生物学报), 2004, 44: 621-626.
[12] Ma QY, Ren JS, Shi HP. Isolation and identification of intestinal flora in giant panda [J]. Beijing Agric(北京农业), 2009,(21): 56-57.
[13] Greetham HL, Giffard C, Hutson RA, et al. Bacteriology of the Labrador dog gut: a cultural and genotypic approach [J]. J Appl Microbiol, 2002, 93: 640-646.
[14] Ding N, Jiang Y, Han L, et al. Bafilomycins and odoriferous sesquiterpenoids from Streptomyces albolongus isolated from Elephas maximus Feces [J]. J Nat Prod, 2016, 79: 799-805.
[15] Viaud S, Saccheri F, Mignot G, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide [J]. Science, 2013, 342: 971-976.
[16] Rea MC, Sit CS, Clayton E, et al. Thuricin CD, a posttrans­lationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile [J]. Proc Natl Acad Sci U S A, 2010, 107: 9352-9357.
[17] Zhao LP, Zhang CH, Fei N, et al. Research development in gut microbiata-targeted nutritional intervention of metabolic diseases [J]. J Chin Inst Food Sci Technol(中国食品学报), 2014,(01): 1-5.
[18] Selvin J, Shanmughapriya S, Gandhimathi R, et al. Optimi­zation and production of novel antimicrobial agents from sponge associated marine actinomycetes Nocardiopsis dasson­villei MAD08 [J]. Appl Microbiol Biotechnol, 2009, 83: 435-445.
[19] Karuppiah V, Li Y, Sun W, et al. Functional gene-based discovery of phenazines from the actinobacteria associated with marine sponges in the South China Sea [J]. Appl Microbiol Biotechnol, 2015, 99: 5939-5950.
[20] Dashti Y, Grkovic T, Abdelmohsen UR, et al. Production of induced secondary metabolites by a co-culture of sponge-associated actinomycetes, Actinokineospora sp. EG49 and Nocardiopsis sp. RV163 [J]. Mar Drugs, 2014, 12: 3046-3059.
[21] Ng YK, Hewavitharana AK, Webb R, et al. Developmental cycle and pharmaceutically relevant compounds of Salinispora actinobacteria isolated from Great Barrier Reef marine sponges [J]. Appl Microbiol Biotechnol, 2013, 97: 3097-3108.
[22] Zhang XY, He F, Wang GH, et al. Diversity and antibacterial activity of culturable actinobacteria isolated from five species of the South China Sea gorgonian corals [J]. World J Microbiol Biotechnol, 2013, 29: 1107-1116.
[23] Li J, Dong JD, Yang J, et al. Detection of polyketide synthase and nonribosomal peptide synthetase biosynthetic genes from antimicrobial coral-associated actinomycetes [J]. Anton Leeuw Int J G, 2014, 106: 623-635.
[24] Nong X, Zhang X, Chen Y, et al. Alkaloids from gorgonian-derived Streptomyces sp. SCSGAA0009 and their antibacterial and antilarval activities [J]. Acta Microbiol Sin(微生物学报), 2013, 53: 995-1000.
[25] Matsui T, Tanaka J, Namihira T, et al. Antibiotics production by an actinomycete isolated from the termite gut [J]. J Basic Microbiol, 2012, 52: 731-735.
[26] Mendes TD, Borges WS, Rodrigues A, et al. Anti-candida properties of urauchimycins from actinobacteria associated with Trachymyrmex ants [J]. Biomed Res Int, 2013, 2013: 835081.
[27] Oh DC, Poulsen M, Currie CR, et al. Dentigerumycin: a bacterial mediator of an ant-fungus symbiosis [J]. Nat Chem Biol, 2009, 5: 391-393.
[28] Dangelo RA, de Souza DJ, Mendes TD, et al. Actinomycetes inhibit filamentous fungi from the cuticle of Acromyrmex leafcutter ants [J]. J Basic Microbiol, 2016, 56: 229-237.
[29] Visser AA, Nobre T, Currie CR, et al. Exploring the potential for actinobacteria as defensive symbionts in fungus-growing termites [J]. Microb Ecol, 2012, 63: 975-985.
[30] Chouvenc T, Efstathion CA, Elliott ML, et al. Extended disease resistance emerging from the faecal nest of a subterra­nean termite [J]. Proc R Soc B, 2013, 280: 20131885.
[31] Lu YH, Li S, Zhou DX, et al. Isolation and identification of termitarium antagonistic actinomycetes BYC 01 and its active metabolites [J]. Acta Microbiol Sin(微生物学报), 2014, 54: 754-759.
[32] Madden AA, Grassetti A, Soriano JA, et al. Actinomycetes with antimicrobial activity isolated from paper wasp(Hymen­optera: Vespidae: Polistinae)nests [J]. Environ Entomol, 2013, 42: 703-710.
[33] Kumar V, Bharti A, Gupta VK, et al. Actinomycetes from solitary wasp mud nest and swallow bird mud nest: isolation and screening for their antibacterial activity [J]. World J Microbiol Biotechnol, 2012, 28: 871-880.
[34] Oh DC, Poulsen M, Currie CR, et al. Sceliphrolactam, a polyene macrocyclic lactam from a wasp-associated Strepto­myces sp. [J]. Org Lett, 2011, 13: 752-755.
[35] Wang XJ, Yan SL, Min CL, et al. Isolation and antimicrobial activities of actinomycetes from vermicompost [J]. China J Chin Mater Med(中国中药杂志), 2015, 40: 614-618.
[36] Jami M, Ghanbari M, Kneifel W, et al. Phylogenetic diversity and biological activity of culturable actinobacteria isolated from freshwater fish gut microbiota [J]. Microbiol Res, 2015, 175: 6-15.
[37] Su H, McKelvey J, Rollins D, et al. Cultivable bacterial microbiota of northern bobwhite(Colinus virginianus): a new reservoir of antimicrobial resistance? [J]. PLoS One, 2014, 9: e99826.
[38] Tang Y, Wang Y, Wang Z, et al. Novel antimicrobial metabolites produced by Sika deer-associated Actinomyces sp. JN411010 [J]. Nat Prod Res, 2013, 27: 2183-2189.
[39] Motohashi K, Takagi M, Shin-Ya K. Tetracenoquinocin and 5-iminoaranciamycin from a sponge-derived Streptomyces sp. Sp080513GE-26 [J]. J Nat Prod, 2010, 73: 755-758.
[40] Wyche TP, Hou Y, Braun D, et al. First natural analogs of the cytotoxic thiodepsipeptide thiocoraline A from a marine Verrucosispora sp. [J]. J Org Chem, 2011, 76: 6542-6547.
[41] Kwon Y, Kim S, Shin Y, et al. A new benzofuran glycoside and indole alkaloids from a sponge-associated rare actinomycete, Amycolatopsis sp. [J]. Mar Drugs, 2014, 12: 2326-2340.
[42] Wei R, Xi T, Li J, et al. Lobophorin C and D, new kijanimicin derivatives from a marine sponge-associated actinomycetal strain AZS17 [J]. Mar Drugs, 2011, 9: 359-368.
[43] Khan ST, Komaki H, Motohashi K, et al. Streptomyces associated with a marine sponge Haliclona sp.; biosynthetic genes for secondary metabolites and products [J]. Environ Microbiol, 2011, 13: 391-403.
[44] Vicente J, Stewart A, van Wagoner R, et al. Monacyclinones, new angucyclinone metabolites isolated from Streptomyces sp. M7_15 associated with the Puerto Rican sponge Scopalina ruetzleri [J]. Mar Drugs, 2015, 13: 4682-4700.
[45] Schneemann I, Kajahn I, Ohlendorf B, et al. Mayamycin, a cytotoxic polyketide from a Streptomyces strain isolated from the marine sponge Halichondria panacea [J]. J Nat Prod, 2010, 73: 1309-1312.
[46] Shin H, Lee H, Lee J, et al. Violapyrones H and I, new cytotoxic compounds isolated from Streptomyces sp. associated with the marine starfish Acanthaster planci [J]. Mar Drugs, 2014, 12: 3283-3291.
[47] Ye X, Anjum K, Song T, et al. A new curvularin glycoside and its cytotoxic and antibacterial analogues from marine actinomycete Pseudonocardia sp. HS7 [J]. Nat Prod Res, 2016, 30: 1156-1161.
[48] Guo ZK, Wang T, Guo Y, et al. Cytotoxic angucyclines from Amycolatopsis sp. HCa1, a rare actinobacteria derived from Oxya chinensis [J]. Planta Med, 2011, 77: 2057-2060.
[49] Kim SH, Ko H, Bang HS, et al. Coprismycins A and B, neuroprotective phenylpyridines from the dung beetle-associated bacterium, Streptomyces sp [J]. Bioorg Med Chem Lett, 2011, 21: 5715-5718.
[50] Lin Z, Marett L, Hughen RW, et al. Neuroactive diol and acyloin metabolites from cone snail-associated bacteria [J]. Bioorg Med Chem Lett, 2013, 23: 4867-4869.
[51] Grkovic T, Abdelmohsen UR, Othman EM, et al. Two new antioxidant actinosporin analogues from the calcium alginate beads culture of sponge-associated Actinokineospora sp. strain EG49 [J]. Bioorg Med Chem Lett, 2014, 24: 5089-5092.
[52] Cheng C, MacIntyre L, Abdelmohsen UR, et al. Biodiversity, anti-trypanosomal activity screening, and metabolomic profiling of actinomycetes isolated from Mediterranean sponges [J]. PLoS One, 2015, 10: e138528.
[53] Tabares P, Pimentel-Elardo SM, Schirmeister T, et al. Anti-protease and immunomodulatory activities of bacteria associ­ated with Caribbean sponges [J]. Mar Biotechnol, 2011, 13: 883-892.
[54] Kim SH, Ko H, Bang HS, et al. Coprismycins A and B, neuroprotective phenylpyridines from the dung beetle-associated bacterium, Streptomyces sp. [J]. Bioorg Med Chem Lett, 2011, 21: 5715-5718.
[55] Park SH, Moon K, Bang HS, et al. Tripartilactam, a cyclobu­tane-bearing tricyclic lactam from a Streptomyces sp. in a dung beetle's brood ball [J]. Org Lett, 2012, 14: 1258-1261.
[56] Oh DC, Scott JJ, Currie CR, et al. Mycangimycin, a polyene peroxide from a mutualist Streptomyces sp. [J]. Org Lett, 2009, 11: 633-636.
[57] Scott JJ, Oh DC, Yuceer MC, et al. Bacterial protection of beetle-fungus mutualism [J]. Science, 2008, 322: 63.
[58] Schneemann I, Wiese J, Kunz AL, et al. Genetic approach for the fast discovery of phenazine producing bacteria [J]. Mar Drugs, 2011, 9: 772-89.
[59] Abdjul DB, Yamazaki H, Kanno S, et al. Haliclonadiamine derivatives and 6-epi-monanchorin from the marine sponge Halichondria panicea collected at Iriomote island [J]. J Nat Prod, 2016, 79: 1149-1154.
[60] Dong Y, Liu W, Lei Y, et al. Effect of gelatin sponge with colloid silver on bone healing in infected cranial defects [J]. Mat Sci Eng C, 2016, 70: 371-377.
[61] Hernandez-Zulueta J, Araya R, Vargas-Ponce O, et al. First deep screening of bacterial assemblages associated with corals of the Tropical Eastern Pacific [J]. FEMS Microbiol Ecol, 2016, 92: fiw196.
[62] Arrigoni R, Berumen ML, Chen CA, et al. Species delimitation in the reef coral genera Echinophyllia and Oxypora(Scleractinia, Lobophylliidae)with a description of two new species [J]. Mol Phylogenet Evol, 2016, 105: 146-159.
[63] Selin-Rani S, Senthil-Nathan S, Thanigaivel A, et al. Toxicity and physiological effect of quercetin on generalist herbivore, Spodoptera litura Fab. and a non-target earthworm Eisenia fetida Savigny [J]. Chemosphere, 2016, 165: 257-267.
[64] Engelmann P, Hayashi Y, Bodo K, et al. Phenotypic and functional characterization of earthworm coelomocyte subsets: linking light scatter-based cell typing and imaging of the sorted populations [J]. Dev Comp Immunol, 2016, 65: 41-52.
[65] Hussain N, Singh A, Saha S, et al. Excellent N-fixing and P-solubilizing traits in earthworm gut-isolated bacteria: a vermicompost based assessment with vegetable market waste and rice straw feed mixtures [J]. Bioresour Technol, 2016, 222: 165-174.
[66] O'Shea-Wheller TA, Wilson-Aggarwal DK, Edgley DE, et al. A social mechanism facilitates ant colony emigrations over different distances [J]. J Exp Biol, 2016, 219: 3439-3446.
[67] Ivanova V, Laatsch H, Kolarova M, et al. Structure elucidation of a new natural diketopiperazine from a Microbispora aerata strain isolated from Livingston island, Antarctica [J]. Nat Prod Res, 2013, 27: 164-170.
相关文献:
1.梁林富, 刘海利, 李玉芬, 马文泉, 郭跃伟, 何文斐.锉海绵属海绵次级代谢产物及其生物活性研究进展[J]. 药学学报, 2014,49(9): 1218-1237
2.李芳芳, 陆盛胜, 吉腾飞, 何坚.动物来源放线菌的次级代谢产物及其生物活性研究进展[J]. 药学学报,